Method for separating medical nuclide yttrium from strontium color layer
Through the method of loading the new amide pod ether extractant to the solid phase material, the separation process of a color layer column is used to solve the problems of complex separation process of 90Y in strontium in the prior art and serious impurity extraction, thus achieving efficient and simple With 90Y separation, the decontamination effect of strontium is significantly improved, and it is suitable for the high-purity preparation of medical nuclides.
Patent Information
- Application Number
- CN202410910143.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-08
- Publication Date
- 2024-11-12
AI Technical Summary
In the prior art, the process of isolating medical nuclide yttrium from strontium is complicated and the extraction of impurity elements is severe, which limits the efficient purity and separation efficiency of 90Y, especially the decontamination effect of 90Sr is poor, which affects the applicability of medical radionuclides. .
The new amide pod ether extractant is loaded onto the solid phase material, and the separation process of a color layer column is carried out, and the DEHDGA resin is used with appropriate diluents and surface modification treatment is used to achieve efficient separation of strontium and yttrium elements, and pass through the aqueous phase. The rinsing and desorption steps of hydrochloric acid solution were obtained to obtain a high-purity 90Y solution.
It achieves efficient separation of 90Y in 90Sr, the decontamination of strontium reaches 106, and the recovery rate of yttrium can reach 96%. The separation effect is better than traditional methods, the process is simple and efficient, the product meets the requirements of the pharmacopoeia, making it convenient for the preparation of medical 90Y.
Smart Images

Figure CN118932194A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a separation technology of chemical elements, in particular to a method for chromatographically separating medical nuclide yttrium from strontium. Background Art
[0002] 90 Y has a short half-life, high beta ray energy, and stable decay daughters, making it a good medical radionuclide. 90 Y is derived from the parent nuclide 90 Sr decays by β, periodically from 90 Separation of Sr 90 Y, can produce high specific activity, carrier-free (NCA) 90 Y. However 90 Sr is a bone-loving, extremely toxic nuclide. 90 The maximum permissible body burden (MPBB) of Sr is very low, only 74 kBq (2 μCi). 90 Y in 90 The Sr content should be as low as possible. 90 Sr / 90 The Y separation factor is at least less than 1×10 -6 (preferably less than 1×10 -8 ). In addition, the pharmacopoeia 90 The maximum limits of the stable element content in Y are specified as shown in Table 1. 90 For Y-labeled targeted drugs, a high total impurity content will cause problems such as low targeted drug labeling rate or radionuclide shedding.
[0003] Table 1 90 Impurity limits in Y
[0004]
[0005] Carrier-free 90 Y and 90 The separation of Sr has always been a challenging task. Conventional chromatography 90 Y and 90 The method for Sr is to extract it from a dilute acid solution using a resin containing di(2-ethylhexyl)phosphoric acid (HDEHP). 90 Y, then stripped with 8 mol / L HCl solution, but after separation on a chromatographic column, the Sr removal was only 10 3 After 3 consecutive chromatographic separations 90 Y in 90 The Sr content dropped to 10 -8 Or use a resin containing an amide pod ether extractant (DGA resin) in combination with a resin containing a crown ether to obtain a higher purity 90Y. The complicated column separation process is the main obstacle limiting its widespread applicability and acceptability. Summary of the invention
[0006] The purpose of the present invention is to provide a method for chromatographically separating medical nuclides yttrium from strontium in view of the defects existing in the prior art. A new type of amide pod ether reagent is loaded into a solid phase material, and while achieving good separation of strontium and yttrium elements, as few impurity elements as possible are extracted into the organic phase, thereby shortening the overall separation process and improving the separation process efficiency.
[0007] To achieve the above object, the technical solution of the present invention is as follows:
[0008] A method for chromatographically separating medical nuclide yttrium from strontium comprises the following steps:
[0009] (1) dissolving N,N-di(2-ethylhexyl)diglyamide acid in an organic solvent, washing to remove interfering elements in the extractant, and rotary evaporating to remove the organic solvent;
[0010] (2) adding an appropriate amount of diluent to the extractant and adding a solid phase separation resin material, stirring evenly and standing for a period of time, removing the solvent and washing the DEHDGA resin with deionized water, and drying to constant weight;
[0011] (3) Prepare a chromatographic column with DEHDGA resin and add 90 Sr solution, 90 Y nuclide is adsorbed on DEHDGA resin;
[0012] (4) Wash the chromatographic column with water and then desorb with hydrochloric acid solution to obtain high-purity 90 Y solution.
[0013] In a specific embodiment, in the method for chromatographically separating medical nuclides yttrium from strontium as described above, in step (1), the concentration of N,N-di(2-ethylhexyl)diglyamide acid in the extractant is 0.3-1 mol / L; and the organic solvent comprises petroleum ether or cyclohexane.
[0014] Furthermore, in step (1), the extractant is washed with 1-1.2 mol / L hydrochloric acid to remove interfering elements in the extractant; and the organic solvent in the extractant is removed by a rotary evaporator.
[0015] In a specific embodiment, in the method for chromatographically separating medical nuclides yttrium from strontium as described above, in step (2), a solid phase separation resin material is added to an extractant, the content of the extractant being 10 to 30% of the total mass; and the diluent comprises dichloromethane, acetone or methanol.
[0016] Furthermore, the solid phase separation resin material described in step (2) can specifically be polymethyl methacrylate resin, polystyrene resin, mesoporous silica resin or silica gel.
[0017] In a specific embodiment, in the method for chromatographically separating medical nuclides yttrium from strontium as described above, a surface-modified solid phase separation resin material is used in step (2), and the surface modification method is: adding an appropriate amount of organic solvent to dichloromethane or acetone or methanol solution to dissolve it, and then adding it to the polymethyl methacrylate resin material, the added solvent should be able to completely cover the resin surface and its internal pore size, stirring evenly and standing for a period of time, and then removing the solvent.
[0018] Furthermore, the organic solvent used for resin surface modification in step (2) includes dodecane or toluene.
[0019] Furthermore, in step (2), the solvent is removed by rotary evaporation.
[0020] In a specific embodiment, in the method for chromatographically separating medical nuclide yttrium from strontium as described above, in step (3), DEHDGA resin is loaded into a plastic column to prepare a chromatographic column, and the chromatographic column is equilibrated with an acid solution.
[0021] Furthermore, in step (3) 90 The Sr solution contains 90 0.01-0.4 mol / L nitric acid or hydrochloric acid solution of Sr ions.
[0022] In a specific embodiment, in the method for chromatographically separating medical nuclide yttrium from strontium as described above, in step (4), the aqueous phase is a 0.01-0.4 mol / L nitric acid or hydrochloric acid solution.
[0023] Furthermore, in step (4), an appropriate amount of strontium nitrate is added to the aqueous phase to improve the washing effect.
[0024] Furthermore, in step (4), the chromatographic column is eluted with water for 55 to 60 column volumes, and desorbed with hydrochloric acid solution for 5 to 6 column volumes.
[0025] Furthermore, in step (4), the concentration of the hydrochloric acid solution is 1 to 1.2 mol / L.
[0026] In a specific embodiment, the method for chromatographic separation of medical nuclides yttrium from strontium as described above can also be used to separate medical nuclides yttrium from irradiated high-abundance 86 Chromatographic separation of Sr in solution 86 The Y element.
[0027] The beneficial effects of the present invention are as follows: The chromatographic separation process established by the present invention can be realized by using only one chromatographic column. 90 Sr.90 Highly efficient separation of Y, decontamination of strontium up to 10 6 The yttrium recovery rate can reach 96%, and the separation effect is better than the classic HDEHP chromatography separation process. Compared with the chromatography separation process of pod ether and crown ether, the present invention has the advantages of simple steps and high separation efficiency. In addition, the final product of the process of the present invention is in HCl solution, which is consistent with the medium required in the pharmacopoeia, and is convenient for medical use. 90 In addition, in the process of solid phase resin material synthesis, the present invention proposes a new method for improving the Kd value (resin distribution coefficient) of the solid phase material, which can effectively reduce the interaction between the active functional groups in the extractant and the solid phase material, and improve the effect of the synthetic material on the target element. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 The present invention is a flow chart of a method for chromatographically separating medical nuclide yttrium from strontium in a specific embodiment of the present invention. DETAILED DESCRIPTION
[0029] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0030] The present invention is directed to 90 The Y separation process is complicated and the impurity elements in the HDEHP process are seriously extracted. A new separation process is established to improve the traditional separation method. A method for separating medical nuclides yttrium from strontium by chromatography is proposed, such as Figure 1 As shown, the following steps are included:
[0031] (1) dissolving N,N-di(2-ethylhexyl)diglyamide acid (DEHDGA) in an organic solvent such as petroleum ether or cyclohexane to prepare an extractant at a concentration of 0.3 to 1 mol / L, and washing the extractant with 1 to 1.2 mol / L hydrochloric acid to remove interference from natural elements in the extractant, and then removing the organic solvent by rotary evaporation;
[0032] (2) adding an appropriate amount of dichloromethane, acetone or methanol to the extractant for dilution, and adding a solid phase separation resin material, wherein the extractant content accounts for 10 to 30% of the total amount, stirring evenly and standing for a period of time, removing the solvent by a rotary evaporation process, washing the DEHDGA resin with deionized water, and drying to constant weight;
[0033] (3) Load DEHDGA resin into a plastic column to make a chromatography column, and add 90 Sr solution, 90 Y element is extracted into DEHDGA resin; 90 The Sr solution contains90 0.01-0.4 mol / L nitric acid or hydrochloric acid solution of Sr ions;
[0034] (4) The chromatographic column is washed with water for 55 to 60 column volumes, and then desorbed with 1 to 1.2 mol / L hydrochloric acid solution for 5 to 6 column volumes to obtain high-purity 90 Y solution; the aqueous phase is a 0.01-0.4 mol / L nitric acid or hydrochloric acid solution, and an appropriate amount of strontium nitrate can be added to the aqueous phase to improve the washing effect.
[0035] The solid phase separation resin material described in step (2) of the above method can be specifically polymethyl methacrylate resin (such as CG71 resin produced by Dow), polystyrene resin, mesoporous silica resin or silica gel. Since the active functional group in DEHDGA is -H, it may have a hydrogen bond with the carbonyl group in the polymethyl methacrylate resin, resulting in the synthetic resin having a negative effect on the K of Y. d In order to reduce the interaction between the active functional groups in the extractant and the solid phase material and improve the effect between the synthetic material and the target element, the resin is surface modified in step (2) as follows:
[0036] Take a certain amount of solvent (such as dodecane, toluene, etc.) and add dichloromethane, acetone or methanol solution to dissolve, add to the solid phase separation resin material (the solid phase separation resin material support is not limited to the CG71 resin produced by Dow, and polymethyl methacrylate resins produced by other companies can also be used), stir overnight, and use rotary evaporation to remove the solvent. The amount of solvent added needs to be calculated based on the solvent density and the specific surface area of the resin, so that the added solvent can completely cover the resin surface and its internal pore size, that is, complete the resin surface loading.
[0037] The present invention is not limited to 90 Separation of Sr 90 Y, also applicable to high abundance from irradiation 86 Separation of Sr 86 Y, the separation process is the same as the above method.
[0038] Medical Nuclides 90 The separation requirements and conditions of Y are quite different from those of elements in nuclear fuel reprocessing. The present invention applies it to medical nuclides based on its extraction performance. 90 Y and 90The present invention has been applied to the separation of Y and Sr, and achieved good separation effect. Since DEHDGA has a strong ability to complex metal ions, in most reports it is difficult for the extractant to strip the complexed metal ions. The present invention uses HCl as a stripping agent based on the complexing mechanism of DEHDGA and the weak hydration ability of HCl, and successfully strips Y from DEHDGA. Although there are certain by-products in the synthesis process of DEHDGA, the content of the by-products is low, and good separation effect can be achieved without purification. The present invention uses DEHDGA to have good selectivity for Y, and after separation on a chromatography column, the Sr decontamination is as high as 10 6 In the process of solid phase material synthesis, the present invention proposes a new method for increasing the Kd value of the solid phase material, which can effectively reduce the interaction between the active functional groups in the extractant and the solid phase material, and improve the effect of the synthetic material and the target element.
[0039] Example 1
[0040] A method for chromatographically separating medical nuclides yttrium from strontium, comprising purification of an extractant, preparation of a resin, and establishment of a chromatographic separation method. The acid used in the separation process is subjected to sub-boiling distillation, and the impurity content is not less than UPS grade. The water used is triple distilled water. The specific operation steps of the separation process are as follows:
[0041] 1) DEHDGA Extract Purification
[0042] DEHDGA was dissolved in petroleum ether to prepare an extractant, the concentration of DEHDGA was 0.3 mol / L, and washed with 1 mol / L hydrochloric acid for 3 times to remove the interference of natural elements in the extractant. The petroleum ether in the extractant was removed by a rotary evaporator.
[0043] 2) Preparation of DEHDGA resin
[0044] Add a certain amount of dichloromethane, acetone or methanol to an appropriate amount of extractant to dilute it, add a certain amount of silica gel, the extractant content accounts for 10% of the total mass, and the solution should be able to cover the silica gel. Stir overnight, remove the solvent by rotary evaporation, wash the resin with deionized water, and place it in an oven to dry to constant weight.
[0045] 3) DEHDGA chromatography separation
[0046] Take 0.5mL of DEHDGA resin and wet-load it into a plastic column (column diameter 4mm), balance the column with acid solution; add 90 Sr(about 10 -4 mol / L) solution, 90 Element Y is adsorbed to DEHDGA resin; 90 The Sr solution contains 90 0.01 mol / L nitric acid solution of Sr ions;
[0047] 4) Elute the column with 0.01 mol / L nitric acid solution for 60 column volumes, then desorb with 1 mol / L hydrochloric acid solution for 6 column volumes to obtain high purity 90 Y solution: 100 μg / L strontium nitrate can be added to the elution water phase to improve the washing effect.
[0048] The above chromatography separation process has a Y yield of 95.3% and a Sr decontamination of 2.8×10 6 .
[0049] Example 2
[0050] A method for chromatographically separating medical nuclides yttrium from strontium, comprising purification of an extractant, preparation of a resin, and establishment of a chromatographic separation method. The acid used in the separation process is subjected to sub-boiling distillation, and the impurity content is not less than UPS grade. The water used is triple distilled water. The specific operation steps of the separation process are as follows:
[0051] 1) DEHDGA Extract Purification
[0052] DEHDGA was dissolved in cyclohexane to prepare an extractant with a DEHDGA concentration of 1 mol / L, and washed three times with 1.2 mol / L hydrochloric acid to remove the interference of natural elements in the extractant. The cyclohexane in the extractant was removed by a rotary evaporator.
[0053] 2) Preparation of DEHDGA resin
[0054] Add a certain amount of dichloromethane to an appropriate amount of extractant to dilute it, add a certain amount of polystyrene resin, the extractant content accounts for 30% of the total mass, and the solution should be able to cover the resin. Stir overnight, remove the solvent by rotary evaporation, wash the resin with deionized water, and place it in an oven to dry to constant weight.
[0055] 3) DEHDGA chromatography separation
[0056] Take 0.5mL of DEHDGA resin and wet-load it into a plastic column (column diameter 4mm), balance the column with acid solution; add 90 Sr(about 10 -4 mol / L) solution, 90 Element Y is adsorbed to DEHDGA resin; 90 The Sr solution contains 90 0.3 mol / L hydrochloric acid solution of Sr ions;
[0057] 4) Elute the column with 0.4 mol / L hydrochloric acid solution for 55 column volumes, then desorb with 1.2 mol / L hydrochloric acid solution for 5 column volumes to obtain high purity 90Y solution: 100 μg / L strontium nitrate can be added to the aqueous phase to improve the washing effect.
[0058] The above chromatography separation process has a Y yield of 96.4% and a Sr decontamination of 1.1×10 6 .
[0059] Example 3
[0060] A method for chromatographically separating medical nuclides yttrium from strontium, comprising purification of extractant, preparation and improvement of resin, and establishment of chromatographic separation method, wherein the acid used in the separation process is sub-boiling distilled, the impurity content is not less than UPS grade, and the water used is triple distilled water. The specific operation steps of the separation process are as follows:
[0061] 1) DEHDGA Extract Purification
[0062] DEHDGA was dissolved in petroleum ether to prepare an extractant, the concentration of DEHDGA was 0.8 mol / L, and washed with 1 mol / L hydrochloric acid for 3 times to remove the interference of natural elements in the extractant. The petroleum ether in the extractant was removed by a rotary evaporator.
[0063] 2) Preparation of modified DEHDGA resin
[0064] Take 0.1-0.2 g of an organic solvent (such as dodecane, toluene, etc.) and add dichloromethane to dissolve it, add 5 g of CG71 resin, stir overnight, and remove the solvent by rotary evaporation.
[0065] Add a certain amount of dichloromethane to an appropriate amount of extractant to dilute it, add a certain amount of surface-modified CG71 resin (the solid phase separation material support is not limited to the CG71 resin produced by Dow, and polymethyl methacrylate resins produced by other companies can also be used), the extractant content accounts for 16% of the total mass, and the solution should be able to cover the resin. Stir overnight, remove the solvent by rotary evaporation, wash the resin with deionized water, and place it in an oven to dry to constant weight.
[0066] Take 0.1g of the surface-modified resin and add 5mL of 0.1mol / L nitric acid solution containing Y, shake at constant temperature for 30 minutes and then separate the phases. d The values are shown in Table 2. It can be seen that the new method can d The value increased by 4-6 times.
[0067] Table 2 Comparison of the adsorption capacity of three resins for Y
[0068]
[0069]
[0070] 3) DEHDGA chromatography separation
[0071] Take 0.5mL of DEHDGA resin and wet-load it into a plastic column (column diameter 4mm), balance the column with acid solution; add 90 Sr(about 10 -4 mol / L) solution, 90 Element Y is adsorbed to DEHDGA resin; 90 The Sr solution contains 90 0.2 mol / L nitric acid solution of Sr ions;
[0072] 4) Elute the column with 0.2 mol / L nitric acid solution for 60 column volumes, then desorb with 1 mol / L hydrochloric acid solution for 6 column volumes to obtain high purity 90 Y solution: 100 μg / L strontium nitrate can be added to the aqueous phase to improve the washing effect.
[0073] The above chromatography separation process has a Y yield of 95.3% and a Sr decontamination of 6.7×10 6 .
[0074] Those skilled in the art will readily conceive of other embodiments of the present invention after considering the specification and practicing the invention disclosed herein. This application is intended to cover any variations, uses or adaptations of the present invention that follow the general principles of the present invention and include common knowledge or customary techniques in the art that are not disclosed by the present invention. Thus, if these variations and use adaptations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and use adaptations.
[0075] The above embodiments are merely illustrative of the present invention, and the present invention may also be implemented in other specific ways or other specific forms without departing from the gist or essential features of the present invention. Therefore, the described embodiments should be considered illustrative rather than restrictive in any respect. The scope of protection of the present invention should be described by the claims, and any changes equivalent to the intent and scope of the claims should also be included within the scope of the present invention.
Claims
1. A method for chromatographically separating medical nuclides of yttrium from strontium, characterized in that: The steps include: (1) dissolving N,N-di(2-ethylhexyl)diglyamide acid in an organic solvent, washing to remove interfering elements in the extractant, and rotary evaporating to remove the organic solvent; (2) adding an appropriate amount of diluent to the extractant and adding a solid phase separation resin material, stirring evenly and standing for a period of time, removing the solvent and washing the DEHDGA resin with deionized water, and drying to constant weight; (3) Prepare a chromatographic column with DEHDGA resin and add 90 Sr solution, 90 Y nuclide is adsorbed on DEHDGA resin; (4) Wash the chromatographic column with water and then desorb with hydrochloric acid solution to obtain high-purity 90 Y solution.
2. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: In step (1), the concentration of N,N-di(2-ethylhexyl)diglycinic acid in the extractant is 0.3-1 mol / L.
3. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1 or 2, characterized in that: The organic solvent described in step (1) includes petroleum ether or cyclohexane.
4. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1 or 2, characterized in that: In step (1), the extractant is washed with 1-1.2 mol / L hydrochloric acid to remove interfering elements in the extractant; and the organic solvent in the extractant is removed by a rotary evaporator.
5. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: In step (2), the solid phase separation resin material is added to the extractant, and the content of the extractant accounts for 10 to 30% of the total mass.
6. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: The diluent described in step (2) includes dichloromethane, acetone or methanol.
7. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1 or 5, characterized in that: The solid phase separation resin material described in step (2) can specifically be polymethyl methacrylate resin, polystyrene resin, mesoporous silica resin or silica gel.
8. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: In step (2), a surface-modified solid phase separation resin material is used. The surface modification method is: adding an appropriate amount of organic solvent to dichloromethane, acetone or methanol solution to dissolve it, and then adding it to the polymethyl methacrylate resin material. The added solvent should be able to completely cover the resin surface and its internal pore size. Stir evenly and let it stand for a period of time, and then remove the solvent.
9. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 8, characterized in that: The organic solvent used for resin surface modification in step (2) includes dodecane or toluene.
10. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: In step (2), the solvent is removed by rotary evaporation.
11. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: In step (3), DEHDGA resin is loaded into a plastic column to prepare a chromatography column, and the chromatography column is equilibrated with an acid solution.
12. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: As described in step (3) 90 The Sr solution contains 90 0.01-0.4 mol / L nitric acid or hydrochloric acid solution of Sr ions.
13. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: In step (4), the aqueous phase is a 0.01-0.4 mol / L nitric acid or hydrochloric acid solution.
14. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 13, characterized in that: In step (4), an appropriate amount of strontium nitrate is added to the aqueous phase to improve the washing effect.
15. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: In step (4), the chromatographic column is eluted with water for 55 to 60 column volumes, and desorbed with hydrochloric acid solution for 5 to 6 column volumes.
16. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: In step (4), the concentration of the hydrochloric acid solution is 1 to 1.2 mol / L.
17. The method for chromatographically separating medical nuclides yttrium from strontium according to claim 1, characterized in that: This method can also be used to irradiate high abundance 86 Chromatographic separation of Sr in solution 86 The Y element.
Citation Information
Cited By
Method and system for separating yttrium [ 90y] from mother liquor containing strontium [ 90sr]
WO2026091316A1
Generator for separating yttrium [ 90y] from strontium [ 90sr]-containing mother liquor, and separation method
WO2026137541A1
